Wake Forest | GenomeWeb

Wake Forest

NEW YORK (GenomeWeb News) – Wake Forest University and spin-out company NanoMedica have received $860,000 in funding to move a bead-based genetic sequencing drug discovery technology closer to commercialization, Wake Forest said today.

Beyond the SNP


Genome-wide association studies have put forward a vast number of SNPs associated with disease. Once you have those SNPs, the search is on for the causal variant.

News Scan


Thermo Fisher Scientific, North Carolina Biotechnology Center, Life Technologies, Cenix BioScience, AstraZeneca, MultiCell Technologies, Maxim Biotech, CyBio, Axxam, PerkinElmer, Sangmyung University

Tech Transfer Tidbits


JumpStart and Case Tech Ventures Invest in Neuros Medical; OGI Bets on UWO Spinout Cytognomix; Forma Collaborates with Singapore's ETC; and more …

For now, the center is planning how to create a venue that would grow the state's established biotech sector by capitalizing on the nanotech sector that has emerged in recent years in its Piedmont Triad region.

People in the News


Bruno Sobral, Michael Gilman, Kathy Gibson, Uwe Christians,Herbert Fritsche, Dan Crowther

Direct-to-consumer genetic testing companies have based their products on what scientists have accomplished, but the caveat is that the science is still in its early days.

A majority of US tech-transfer offices said their main goals are to provide a service to faculty entrepreneurs and translate university research into commercial products — but much less so to maximize licensing revenue or provide research support, according to the survey.

News Briefs


Cerenis, Montreal Heart Institute, UVA, Ortho Clinical, Mirna, UCSF, Case Western, Diagnostic Hybrids, iBridge Network, Ben Franklin Tech Partners, and more…

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.